As of 4:02pm ET
| -0.49 / -0.93%|
The 22 analysts offering 12-month price forecasts for Fresenius Medical Care AG & Co KGaA have a median target of 56.61, with a high estimate of 65.80 and a low estimate of 47.00. The median estimate represents a +8.25% increase from the last price of 52.29.
The current consensus among 25 polled investment analysts is to Buy stock in Fresenius Medical Care AG & Co KGaA. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.